It has demonstrated an altered excretion pathway in humans leading to significantly lower bladder activity (Green et al. 2020; Wang 2023) as well as improved tumor detection characteristics compared to [68Ga]Ga-PSMA-11 in the same patient, particularly in individuals with diagnosis of a low/intermediate risk PCa (Wang 2023). The gene discussed is FOLH1; the disease is posterior cortical atrophy.